Table 1 Characteristics of participants according to stroke and CAS status
From: Elevated RANTES levels are associated with increased risk of cerebral atherosclerotic stenosis
Variables | Non-AIS (n = 65) | AIS (n = 62) | p-value | Non-AIS | AIS | ||||
|---|---|---|---|---|---|---|---|---|---|
Non-CAS (n = 26) | CAS (n = 39) | p-value | Non-CAS (n = 23) | CAS (n = 39) | p-value | ||||
Age | 59.95 ± 1.32 | 54.23 ± 1.48 | 0.019 | 59.85 ± 2.05 | 58.34 ± 1.75 | 0.581 | 53.13 ± 2.57 | 54.87 ± 1.82 | 0.575 |
Male, n (%) | 45 (69.2) | 50 (80.6) | 0.139 | 15 (57.7) | 30 (76.9) | 0.100 | 18 (78.3) | 32 (82.1) | 0.715 |
Smoking, n (%) | 28 (43.1) | 26 (41.9) | 0.879 | 8 (30.8) | 20 (51.3) | 0.102 | 7 (30.4) | 19 (48.7) | 0.159 |
Drinking, n (%) | 25 (38.5) | 23 (37.1) | 0.874 | 9(34.6) | 16 (41.0) | 0.603 | 5 (34.8) | 15 (38.5) | 0.772 |
Medical history, n (%) | |||||||||
Prior stroke/TIA | 11 (16.9) | 10 (16.1) | 0.904 | 2 (7.7) | 9 (23.1) | 0.177 | 3 (13.0) | 7 (17.9) | 0.731 |
CAD | 5 (7.7) | 7 (11.3) | 0.488 | 3 (11.5) | 2(5.1) | 0.382 | 4 (17.4) | 3 (7.7) | 0.408 |
Hypertension | 40 (61.5) | 37 (59.7) | 0.830 | 16 (61.5) | 24 (61.5) | 1.000 | 13 (56.5) | 24 (61.5) | 0.791 |
Diabetes mellitus | 19 (29.2) | 13 (21.0) | 0.284 | 5 (19.2) | 14 (35.9) | 0.148 | 5 (21.7) | 8 (20.5) | 0.909 |
Hyperlipidemia | 6 (9.2) | 7 (11.3) | 0.702 | 2 (7.7) | 4 (10.3) | 1.000 | 4 (17.4) | 3 (7.7) | 0.408 |
Laboratory findings | |||||||||
TC, mmol/L | 3.67 ± 0.12 | 3.27 ± 0.11 | 0.019 | 3.80 ± 0.18 | 3.59 ± 0.17 | 0.422 | 3.36 ± 0.19 | 3.22 ± 0.14 | 0.552 |
Triglyceride, mmol/L | 1.43 ± 0.13 | 1.39 ± 0.12 | 0.830 | 1.43 ± 0.15 | 1.43 ± 0.19 | 0.989 | 1.43 ± 0.21 | 1.37 ± 0.14 | 0.783 |
HDL-C, mmol/L | 1.02 ± 0.03 | 0.91 ± 0.03 | 0.005 | 1.06 ± 0.04 | 0.99 ± 0.04 | 0.218 | 0.90 ± 0.04 | 0.91 ± 0.03 | 0.824 |
LDL-C, mmol/L | 2.27 ± 0.11 | 1.99 ± 0.10 | 0.061 | 2.33 ± 0.16 | 2.22 ± 0.14 | 0.603 | 2.06 ± 0.80 | 1.95 ± 0.12 | 0.594 |
Creatinine, µmol/L | 72.71 ± 2.25 | 73.22 ± 2.43 | 0.878 | 72.0 ± 3.21 | 73.19 ± 3.12 | 0.798 | 72.57 ± 3.51 | 73.61 ± 3.30 | 0.838 |
eGFR, ml/min/1.73m2 | 92.43 ± 1.93 | 95.76 ± 2.18 | 0.254 | 90.69 ± 2.51 | 95.60 ± 2.77 | 0.464 | 97.19 ± 3.27 | 94.91 ± 2.89 | 0.616 |
Fasting glucose, mmol/L | 5.76 ± 0.24 | 5.84 ± 0.29 | 0.826 | 5.74 ± 0.39 | 5.77 ± 0.32 | 0.941 | 5.87 ± 0.59 | 5.83 ± 0.31 | 0.950 |
HbA1c, % | 6.46 ± 0.20 | 6.44 ± 0.22 | 0.936 | 6.28 ± 0.27 | 6.58 ± 0.27 | 0.463 | 6.34 ± 0.34 | 6.50 ± 0.30 | 0.719 |
Platelet count (× 109/L) | 221.92 ± 8.01 | 221.73 ± 7.44 | 0.987 | 221.8 ± 13.5 | 222.7 ± 10.1 | 0.908 | 221.16 ± 9.96 | 221.16 ± 10.32 | 0.920 |